Search results
Novavax Inc (NVAX) Reports Mixed Q3 Results Amid Cost Reduction Efforts and Vaccine Approvals
GuruFocus.com via Yahoo Finance· 6 months agoNovavax Inc (NASDAQ:NVAX) reported total revenue of $187 million for Q3 2023, a significant decrease...
EMA Panel Endorses Novavax's (NVAX) COVID Jab for Full Approval
Zacks via Yahoo Finance· 11 months agoNovavax's (NVAX) protein-based COVID-19 vaccine gets recommendation for full marketing authorization...
Novavax seeks FDA approval for COVID booster
ABC News via Yahoo News· 2 years agoNovavax has submitted an application to the Food and Drug Administration for Emergency Use Authorization of its COVID-19 vaccine as a booster in adults...
Novavax's (NVAX) COVID-19 Jab Gets Approval in Switzerland
Zacks via Yahoo Finance· 2 years agoNovavax (NVAX) receives expanded temporary authorization for Nuvaxovid, its COVID-19 vaccine, in...
Novavax Covid vaccine becomes fourth to receive FDA approval
The Independent via Yahoo News· 2 years agoThe Food and Drug Administration authorised the use of Novavax Covid-19 vaccine for adults on...
Novavax's COVID-19 Vaccine Gets Back To Back Approval In Japan, Australia For Adolescents
Benzinga via Yahoo Finance· 2 years agoNovavax Inc's (NASDAQ: NVAX) Nuvaxovid (NVX-CoV2373) COVID-19 vaccine received expanded...
Novavax Covid Vaccine Could Soon Win EUA Approval — And So What?
TipRanks via Yahoo Finance· 2 years agoAt long last, Novavax (NVAX) may be close to getting its EUA. As the company announced late Tuesday,...
Novavax (NVAX) to Report Q2 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 years agoWe expect investors to focus on the sales performance of Novavax’s NVAX protein-based COVID-19...
Novavax Posted a Profit in Q2. Here's Why It Doesn't Matter
Motley Fool· 9 months agoNovavax (NASDAQ: NVAX) has gone from a pandemic darling to a bust, with its shares falling by a...
Novavax Tanks On New Troubles For Its Newly Authorized Covid Vaccine
Investor's Business Daily· 2 years agoNovavax won Food and Drug Administration approval for its Covid vaccine — ending a six-month wait —...